LIGANDRO LLGD-4033
Description:
Puretech Ligandrol LGD-4033 (SARMS) contains LGD-4033, a non‑steroidal SARM that binds selectively to androgen receptors in muscle and bone tissue with high affinity and tissue selectivity. In preclinical and early clinical studies, LGD-4033 has demonstrated anabolic activity in muscle, anti‑resorptive and anabolic effects in bone, and increased lean body mass with minimal androgenic activity in the prostate compared to traditional steroids. The product is supplied as 10 mg capsules, 30 per bottle, intended for controlled research applications or advanced performance contexts where such substances are legally permitted, not as an approved therapeutic.
Note: The points below are based on preclinical and limited clinical trial data and are not approved medical claims; LGD-4033 is not authorized as a treatment in most countries.
- Supports significant increases in lean body mass and muscle strength, with phase 2 clinical data showing gains ranging from 4.8% to 9.1% at doses of 0.5–2 mg per day over 12 weeks in hip fracture populations.
- Demonstrates positive effects on bone mineral density and periosteal bone formation in preclinical models, which led to its original development for conditions such as osteoporosis and muscle wasting.
- Shows potential to improve physical function, reduce recovery time between training sessions, and enhance stamina and endurance in experimental settings, making it of interest for sarcopenia, cachexia, and functional limitations.
- There is no established, regulatory‑approved dosing regimen for LGD-4033 outside research trials; any use in people should follow local laws and ideally occur within a formal research or clinical protocol.
- Puretech Ligandrol LGD-4033 provides 10 mg per capsule; clinical studies have used doses ranging from 0.5 to 2 mg per day, while some non‑clinical sources discuss cycles of 5–10 mg per day for 8 weeks, though such protocols are not medically validated and must not be self‑administered.
- If used within an authorized research setting, capsules should be taken consistently, with baseline and serial monitoring of lean mass, bone density, liver enzymes, lipid profile, testosterone and other hormones, and any adverse events.
- LGD-4033 is not approved for general human consumption; medium‑ and long‑term safety data are lacking, and regulatory and sports integrity bodies warn against its unsupervised use for performance or physique enhancement.
- Documented or reported adverse effects include suppression of endogenous testosterone production (often requiring post‑cycle therapy), elevations in liver enzymes, negative impacts on serum lipids, fluid retention, joint pain, testicular discomfort, and potential worsening of cardiovascular risk factors.
- As with other SARMs, there is a significant risk of product contamination, mislabeling, unknown long‑term toxicity, and sanctions under anti‑doping regulations; this product should be kept out of reach of children and handled only where legally permitted and under qualified oversight, not used as a substitute for approved medical therapies.
Puretech Ligandrol LGD-4033 is GMP‑produced with full traceability from raw material to finish. Independent labs confirm >99% purity via HPLC, with zero detectable impurities or microbes. Encapsulated for superior absorption and stability—your trusted source for clean, consistent power.